Hartford (Conn.) HealthCare is the first healthcare system in the state to utilize Caesarea, Israel-based Mazor Robotics’ Mazor X for spine surgeries.
Dublin, Ireland-based Medtronic announced the pricing of $2 billion-worth of senior notes.
Cambridge, Mass.-based InVivo Therapeutics announced the newest patient enrollee into its Inspire Study at Camden, N.J.-based Cooper Neurological Institute.
Zimmer Biomet led the $6.5 billion global hip replacement implant market in 2015.
Dublin, Ireland-based Mainstay Medical reported its full-year 2016 results, with its operating expenses totaling $16.8 million.
Caesarea, Israel-based Mazor Robotics is co-marketing and promoting its Mazor X technology with Medtronic.
Richard H. Bundschu, MD, of Bradenton, Fla.-based Coastal Orthopedics Sports Medicine & Pain Management, is a principal investigator for Nevro’s spinal cord stimulator study.
Houston-based Spine Injury Solutions, also known as SPIN, opened a Lubbock, Texas location as part of its affiliate expansion program.
Menlo Park, Calif.-based Asterias Biotherapeutics announced the sixth and final patient was administered AST-OPC1 after complete paralysis, and has exhibited positive signs following the six-month study.
Maple Grove, Minn.-based CVRx President and CEO Namid Yared was named chairman of Washington, D.C.-based AdvaMed’s board of directors.
More articles on devices:
Orthopedic, neurosurgery & cardiac fields spurring global medical robots market: 4 insights
Spine Injury Solutions expands — 5 things to know
Invivo announces 13th Inspire Study enrollee — 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
